Evolution in Massive and SubMassive Pulmonary Embolism Treatment Part 1
March 3, 2021 through March 3, 2022
Target Audience
The webinar is designed to meet the needs of cardiologists, surgeons, internists, residents, fellows in training, nurses, nurse practitioners, physician assistants, pharmacists, health care technicians, and other health care providers and investigators who participate in the management of patients with coronary, peripheral, structural, and arrhythmic cardiovascular diseases.
Educational Goal
The purpose of this educational activity is to provide participants with knowledge of acute pulmonary embolism treatment.
Learning Objectives
- Explain the importance of PERT program and its importance on clinical outcomes
- Discuss the components of a system wide PERT program and how it can be functional
- Identify best patients for anticoagulation alone, lysis, endovascular embolectomy, or systemic lysis
- Describe steps for catheter directed pharmaco-mechanical lysis, including facilitated lysis
- Discuss steps for endovascular thrombectomy
Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of CMEsolutions and Cardiovascular Innovations Foundation. The CMEsolutions is accredited by the ACCME to provide continuing medical education for physicians.
The CMEsolutions designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits.™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Start Date: March 3, 2021 End Date: March 3, 2022
Participation Requirements
- Read CME Information
- Participate in virtual presentations
- Logon to the following URL: https://online-med-edu.com/cvi/evolution/332021
- Complete evaluation, credit request form, and download or print credit statement
FACULTY AND DISCLOSURES
CMEsolutions requires everyone in a position to control the content of this activity to disclose any relevant financial conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by CMEsolutions for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. CMEsolutions has resolved all conflicts of interest prior to this educational activity.
Vikas Aggarwal, MD
Assistant Professor of Medicine, University of Michigan
Ann Arbor, MI
Vikas Aggarwal has no relevant financial relationships to disclose.
Subhash Banerjee, MD
Chief of Cardiology, VA North Texas Health Care System
Dallas, TX
Subhash Banerjee has disclosed the following relevant financial relationships: AstraZeneca-Speaker’s Bureau; Boston Scientific- Institutional Research Grant; Livmore Inc.-Consultant
Tarek Hammad, MD
Advanced Endovascular Fellow, University Hospitals
Cleveland, OH
Tarek Hammad has no relevant financial relationships to disclose.
Gustavo A. Hereshi, MD
Director of the Pulmonary Vascular and Chronic Thromboembolic Pulmonary Hypertension Program, Department of Pulmonary and Critical Care Medicine Respiratory Institute, Cleveland Clinic
Cleveland, OH
Gustavo Hereshi has no relevant financial relationships to disclose.
Mehdi Shishehbor, DO, MPH, PhD
Director, Cardiovascular Interventional Center, University Hospitals Cleveland Medical Center
Cleveland, OH
Mehdi Shishehbor has no relevant financial relationships to disclose.
Planner Disclosures
No member of CMEsolutions or Cardiovascular Innovations Foundation has any relevant financial relationships to disclose in regards to this activity.
Off-label Use
This activitymay contain discussion of unlabeled and/or investigational uses of agents not approved by the FDA. Please consult the prescribing information for each product.
Commercial Support
Boston Scientific
Inari Medical
Privacy Policy
CMEsolutions Privacy and Confidentiality Policy: www.online-med-edu.com/privacypolicy.pdf
CMEsolutions can be contacted at info@cmesolutions.org .